Nutex Health (NUTX) Gross Margin (2010 - 2026)

Nutex Health (NUTX) has 17 years of Gross Margin data on file, last reported at 42.37% in Q1 2026.

• Quarterly Gross Margin fell 1350.0% year-over-year to 42.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 47.47% (down 130.0% YoY) and the FY2025 annual result came in at 50.76%, up 987.0% from the prior year.
• Gross Margin rose to 42.37% in Q1 2026 per NUTX's latest filing, from 30.42% in the prior quarter.
• The five-year high for Gross Margin was 57.83% in Q3 2025, with the low at 93.21% in Q3 2022.
• Average Gross Margin over 5 years is 22.64%, with a median of 27.82% recorded in 2024.
• Year-over-year, Gross Margin tumbled 15764 bps in 2022 and soared 10448 bps in 2023.
• Nutex Health's Gross Margin stood at 0.99% in 2022, then surged by 1821 bps to 18.97% in 2023, then surged by 190 bps to 54.98% in 2024, then plunged by 45 bps to 30.42% in 2025, then soared by 39 bps to 42.37% in 2026.
• Business Quant data shows NUTX's Gross Margin at 42.37% in Q1 2026, 30.42% in Q4 2025, and 57.83% in Q3 2025.